DACTINOMYCIN News

DACTINOMYCIN currently has 8 news articles, with 22 predicted indications.

This page combines the AI-predicted indications for DACTINOMYCIN with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (22):
- kidney Wilms tumor (99.0%)
- Ewing sarcoma (99.0%)
- Wilms tumor (99.0%)
- adenosarcoma (99.0%)
- gestational trophoblastic neoplasm (99.0%)
- testicular teratoma (99.0%)
- rhabdomyosarcoma (disease) (99.0%)
- spermatocytic seminoma (99.0%)
- seminoma (99.0%)
- testicular cancer (99.0%)
- testicular seminoma (99.0%)
- yolk sac tumor (99.0%)
- testicular germ cell tumor (99.0%)
- relapsing-remitting multiple sclerosis (99.6%)
- botryoid-type embryonal rhabdomyosarcoma of the vagina (99.5%)
- extrahepatic bile duct rhabdomyosarcoma (99.5%)
- embryonal extrahepatic bile duct rhabdomyosarcoma (99.5%)
- parameningeal embryonal rhabdomyosarcoma (99.5%)
- prostate embryonal rhabdomyosarcoma (99.5%)
- liver sarcoma (99.4%)
- upper aerodigestive tract neoplasm (99.2%)
- head and neck cancer (99.2%)